Table 2.
Clinical/Safety Outcomes at 6-month Endpoint Window
BMC (n=58) | Placebo (n=29) | |
---|---|---|
Death | 0 | 1 |
Reinfarction | 1 | 0 |
Repeat Revascularization | 1 | 3 |
Target Vessel | 1 | 2 |
Non-Target Vessel | 0 | 1 |
Heart Failure Hospitalization | 1 | 0 |
ICD Placement | 0 | 2 |
| ||
Total Events | 3 | 6 |
5 | ||
Patients | 3 (5%) | (17%) |